These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 55418)

  • 41. The in vitro production and regulation of anti-double stranded DNA antibodies by peripheral blood mononuclear cells from normals and patients with systemic lupus erythematosus.
    Mach PS; Kharouby M; Lutcher F; Olivier JL; Bazely N; Dougados M; Amor B
    Clin Exp Immunol; 1984 Aug; 57(2):338-44. PubMed ID: 6331922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N; Tsuchida T; Tamaki K
    Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.
    Reefman E; Horst G; Nijk MT; Limburg PC; Kallenberg CG; Bijl M
    Arthritis Rheum; 2007 Oct; 56(10):3399-411. PubMed ID: 17907194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus.
    Charpentier B; Carnaud C; Bach JF
    J Clin Invest; 1979 Aug; 64(2):351-60. PubMed ID: 110833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Depressed effector activity of OKT4+ and OKT8+ T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus.
    Perl A; Gonzalez-Cabello R; Gergely P
    J Clin Lab Immunol; 1984 Oct; 15(2):95-100. PubMed ID: 6240539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
    Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
    J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
    Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
    J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Monocyte (macrophage)-specific antibodies in patients with systemic lupus erythematosus (SLE).
    Shirakawa F; Yamashita U; Suzuki H
    J Clin Immunol; 1987 Mar; 7(2):121-9. PubMed ID: 3571434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nature of cold-reactive antibodies to lymphocyte surface determinants in systemic lupus erythematosus.
    Winfield JB; Winchester RJ; Wernet P; Fu SM; Kunkel HG
    Arthritis Rheum; 1975; 18(1):1-8. PubMed ID: 46753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of anti-alpha2-macroglobulin on K-cell cytolysis and T- and B-cell rosette formation.
    Calder EA; Urbaniak SJ; Irvine WJ; James K
    Clin Exp Immunol; 1975 Oct; 22(1):112-20. PubMed ID: 55326
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced antibody-dependent cell-mediated cytotoxicity in systemic lupus erythematosus.
    Schneider J; Chin W; Friou GJ; Cooper SM; Harding B; Hill RL; Quismorio FP
    Clin Exp Immunol; 1975 May; 20(2):187-92. PubMed ID: 1212807
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus.
    Bluestein HG
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3965-9. PubMed ID: 279013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunofluorescence studies of anti-T cell antibodies and T cells in systemic lupus erythematosus. Selective loss of brightly staining T cells in active disease.
    Steinberg AD; Klassen LW; Budman DR; Williams GW
    Arthritis Rheum; 1979 Feb; 22(2):114-22. PubMed ID: 84675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.
    Yamada A; Winfield JB
    J Clin Invest; 1984 Dec; 74(6):1948-60. PubMed ID: 6210306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monocyte-reactive antibodies in patients with systemic lupus erythematosus.
    Arend WP; Emmerich TE; Sturge JC; Starkebaum GA
    Arthritis Rheum; 1977 Jun; 20(5):1049-57. PubMed ID: 68777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systemic lupus erythematosus sera inhibit antigen presentation by macrophages to T cells.
    Brozek CM; Hoffman CL; Savage SM; Searles RP
    Clin Immunol Immunopathol; 1988 Feb; 46(2):299-313. PubMed ID: 3257427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro activity of anti-DNA antibodies from SLE patients in antibody-dependent cell-mediated cytotoxicity.
    Quismorio FP; Friou GJ; Schneider J; Hutchinson M; Harding B
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):42-7. PubMed ID: 1017897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Macrophage subpopulations in systemic lupus erythematosus.
    Orme J; Mohan C
    Discov Med; 2012 Feb; 13(69):151-8. PubMed ID: 22369974
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Isotype and cytotoxicity spectra of anti-lymphocyte antibodies in patients with systemic lupus erythematosus.
    Edwards BS; Searles RP; Brozek CM; Richards R; Savage SM; Nolla H; Hoffman CL
    Clin Immunol Immunopathol; 1987 Dec; 45(3):333-47. PubMed ID: 3315337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tgamma cells in systemic lupus erythematosus. Variation with disease activity.
    Hamilton ME; Winfield JB
    Arthritis Rheum; 1979 Jan; 22(1):1-6. PubMed ID: 365185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.